Hematopoietic stem and progenitor cells acquire distinct DNA-hypermethylation during in vitro culture

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Weidner, Carola Ingrid ^a   Walenda, Thomas ^a   Lin, Qiong ^a   Wölfler, Monika Martina ^a   Denecke, Bernd ^a   Costa, Ivan Gesteira ^a   Zenke, Martin ^a   Wagner, Wolfgang ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; DNA;

CELL CULTURE; CELL DIFFERENTIATION; COCULTURE; CPG ISLAND; CYTOLOGY; DNA METHYLATION; FETUS BLOOD; GENETICS; HEMATOPOIETIC STEM CELL; HUMAN; IN VITRO STUDY; MESENCHYMAL STROMA CELL; PROCEDURES; PROMOTER REGION; STEM CELL;

ANTIGENS, CD34; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CPG ISLANDS; DNA; DNA METHYLATION; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS; IN VITRO TECHNIQUES; MESENCHYMAL STROMAL CELLS; PROMOTER REGIONS, GENETIC; STEM CELLS;

EID: 84889860158     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03372     Document Type: Article

References (48)

1. Ballen, K. K., Gluckman, E. & Broxmeyer, H. E. Umbilical cord blood transplantation: the first 25 years and beyond. Blood 122, 491-498 (2013).
2. Naldini, L. Ex vivo gene transfer and correction for cell-based therapies. Nat. Rev. Genet. 12, 301-315 (2011).
3. Zhang, C. C., Kaba, M., Iizuka, S., Huynh, H. & Lodish, H. F. Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation. Blood 111, 3415-3423 (2008).
4. Boitano, A. E. et al.Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 329, 1345-1348 (2010).
5. Delaney, C. et al. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat. Med. 16, 232-236 (2010).
6. Robinson, S. N. et al. Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells. Bone Marrow Transplant. 37, 359-366 (2006). (Pubitemid 43250469)
7. Walenda, T. et al. Co-Culture with Mesenchymal Stromal Cells Increases Proliferation and Maintenance of Hematopoietic Progenitor Cells. J. Cell Mol. Med. 14, 337-350 (2010).
8. Jing, D. et al. Hematopoietic stem cells in co-culture with mesenchymal stromal cells - modeling the niche compartments in vitro. Haematologica 95, 542-550 (2010).
9. Okano, M., Bell, D. W., Haber, D. A. & Li, E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation andmammalian development. Cell 99, 247-257 (1999). (Pubitemid 29519904)
10. Tahiliani, M. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930-935 (2009).
11. Yamagata, Y. et al. Lentiviral transduction of CD34(1) cells induces genome-wide epigenetic modifications. PLoS One 7, e48943 (2012).
12. Bibikova, M. et al. High density DNA methylation array with single CpG site resolution. Genomics 98, 288-295 (2011).
13. Walenda, T. et al. Synergistic effects of growth factors and mesenchymal stromal cells for expansion of hematopoietic stem and progenitor cells. Experimental Hematology 39, 617-628 (2011).
14. Koch, C. M. et al. Monitoring of Cellular Senescence by DNA-Methylation at Specific CpG sites. Aging Cell 11, 366-369 (2012).
15. Koch, C. et al. Pluripotent Stem Cells Escape From Senescence-Associated DNA Methylation Changes. Genome Res. 23, 248-259 (2013).
16. Stier, S., Cheng, T., Dombkowski, D., Carlesso, N. & Scadden, D. T. Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood 99, 2369-2378 (2002). (Pubitemid 34525422)
17. Sauvageau, G. et al. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev. 9, 1753-1765 (1995).
18. Schiedlmeier, B. et al. HOXB4's road map to stem cell expansion. Proc. Natl. Acad. Sci. U. S. A 104, 16952-16957 (2007). (Pubitemid 350210971)
19. Irizarry, R. A. et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet. 41, 178-186 (2009).
20. Novershtern, N. et al. Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell 144, 296-309 (2011).
21. Wagner, W. et al. Hematopoietic progenitor cells and cellular microenvironment: behavioral and molecular changes upon interaction. Stem Cells 23, 1180-1191 (2005). (Pubitemid 41377733)
22. Champion, C. et al. Mechanistic insights on the inhibition of c5 DNA methyltransferases by zebularine. PLoS ONE 5, e12388 (2010).
23. Fang, M. Z. et al. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 63, 7563-7570 (2003). (Pubitemid 37466673)
24. Tsai, H. C. et al. Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer Cell 21, 430-446 (2012).
25. Yu, Y. et al. High resolution methylome analysis reveals widespread functional hypomethylation during adult human erythropoiesis. J Biol Chem. 288, 8805-8814 (2013).
26. Broske, A. M. et al. DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nat. Genet. 41, 1207-1215 (2009).
27. Hogart, A. et al. Genome-wide DNA methylation profiles in hematopoietic stem and progenitor cells reveal overrepresentation of ETS transcription factor binding sites. Genome Res. 22, 1407-1418 (2012).
28. Calvanese, V. et al. A promoter DNA demethylation landscape of human hematopoietic differentiation. Nucleic Acids Res. 40, 116-131 (2012).
29. Bock, C. et al. DNA methylation dynamics during in vivo differentiation of blood and skin stem cells. Mol. Cell 47, 633-647 (2012).
30. Ji, H. et al. Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature 467, 338-342 (2010).
31. Anjos-Afonso, F. et al. CD34(2) cells at the apex of the human hematopoietic stem cell hierarchy have distinctive cellular and molecular signatures. Cell Stem Cell 13, 161-174 (2013).
32. Taussig, D. C. et al. Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia. Blood 106, 4086-4092 (2005). (Pubitemid 41775913)
33. Challen, G. A. et al. Dnmt3a is essential for hematopoietic stem cell differentiation. Nat. Genet. 44, 23-31 (2012).
34. Ley, T. J. et al. DNMT3A mutations in acute myeloid leukemia. N. Engl. J. Med. 363, 2424-2433 (2010).
35. Walter, M. J. et al. Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia 25, 1153-1158 (2011).
36. Maunakea, A. K. et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 466, 253-257 (2010).
37. Strathdee, G. et al. Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis. Clin. Cancer Res. 13, 5048-5055 (2007). (Pubitemid 47502069)
38. Wolff, L. & Humeniuk, R. Erythroid versus Myeloid Lineage Commitment: Regulating the Master Regulators. Stem Cells 31, 1237-1244 (2013).
39. Suzuki, M. et al. Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b. Oncogene 25, 2477-2488 (2006).
40. Liu, S. et al. Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia. Cancer Res. 65, 1277-1284 (2005). (Pubitemid 40270154)
41. Ross, K. et al. Polycomb group ring finger 1 cooperates with Runx1 in regulating differentiation and self-renewal of hematopoietic cells. Blood 119, 4152-4161 (2012).
42. Suzuki, M. et al. 5-Azacytidine supports the long-term repopulating activity of cord blood CD34(1) cells. Am. J. Hematol. 77, 313-315 (2004). (Pubitemid 39430714)
43. Milhem, M. et al. Modification of hematopoietic stem cell fate by 5aza 2'deoxycytidine and trichostatin A. Blood 103, 4102-4110 (2004). (Pubitemid 38685350)
44. Stresemann, C., Bokelmann, I., Mahlknecht, U. & Lyko, F. Azacytidine causes complex DNA methylation responses in myeloid leukemia. Mol. Cancer Ther. 7, 2998-3005 (2008).
45. Schallmoser, K. et al. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47, 1436-1446 (2007). (Pubitemid 47101060)
46. Hemeda, H., Kalz, J., Walenda, G., Lohmann, M. & Wagner, W. Heparin concentration is critical for cell culture with human platelet lysate. Cytotherapy 15, 1174-1181 (2013).
47. Walenda, T. et al. Serum after autologous transplantation stimulates self-renewal and proliferation of human hematopoietic progenitor cells. PLoS ONE 6, e18012 (2011).
48. Sandoval, J. et al. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics. 6, 692-702 (2011).